JPRN-UMIN000010324
Completed
未知
Phase II study of Carboplatin plus weekly nab-paclitaxel in elderly patients with non-small cell lung cancer - CBDCA/ weekly nab-PTX for elderly NSCLC patients
orth Japan Lung Cancer Study Group0 sites35 target enrollmentMarch 27, 2013
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- orth Japan Lung Cancer Study Group
- Enrollment
- 35
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Previous treatment with paclitaxel as adjuvant chemotherapy 2\) Active double cancer 3\) Symptomatic brain metastasis 4\) Pleural and peritoneal effusion likely to require surgical intervention, or pericardial effusion 5\) Grade 2 or higher peripheral neuropathy 6\) Radiographically confirmed interstitial pneumonitis or pulmonary fibrosis 7\) Severe concurrent disease (Ischemic heart disease requiring treatment, arrhythmia, cardiac infarction within 6 months before enrollment, hepatic failure, hemorrhagic peptic ulcer, poorly controlled diabetes) 8\) History of Severe drug allergies. 9\) Pregnant females, possibly pregnant females, females wishing to become pregnant and nursing mothers. Males that are currently attempting to produce a pregnancy. 10\) Physician concludes that the patient's participation in this trial is inappropriate.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Phase II study of Carboplatin plus weekly nab-paclitaxel in elderly patients with non-small cell lung cancer using MNASquamous cell lung cancerJPRN-UMIN000012051OSAKA-LCSG30
Completed
Not Applicable
A Phase II Study of biweekly Carboplatin, nab-paclitaxel, and concurrent Thoracic radiation therapy for Patients with local advanced Non-small cell Lung CancerJPRN-UMIN000023802Hirosaki University28
Completed
Phase 2
Phase 2 study of carboplatin and weekly nab-paclitaxel for elderly squamous cell lung cancersquamous cell lung cancerJPRN-UMIN000012025Osaka City General Hospital35
Completed
Not Applicable
A phase II study of concurrent weekly carboplatin and paclitaxel combined with definitive radiotherapy for advanced-stage cervical cancer.terine cervical cancerJPRN-UMIN000017232Osaka University Hospital80
Recruiting
Phase 1
Phase I trial of biweekly Carboplatin plus nab-Paclitaxel with concurrent thoracic radiotherapy in patients with locally advanced non-small cell lung canceron-small cell lung cancerJPRN-UMIN000010480Aomori Prefectural Central Hospital18